Viewing Study NCT02188550


Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2026-02-20 @ 1:32 PM
Study NCT ID: NCT02188550
Status: UNKNOWN
Last Update Posted: 2015-05-19
First Post: 2014-05-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Sponsor: Sinai Hospital of Baltimore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Endometrial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapse or refractory or persistent epithelial ovarian fallopian tube View
None primary peritoneal carcinoma or endometrial cancer View